Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A25932 | 21303916 | Gut | Non-alcoholic fatty liver disease: what's new under the microscope? | 2011 | Details |
A25933 | 21302488 | Zhongguo Zhong Xi Yi Jie He Za Zhi | [Study on somato-type distribution and its correlations with body mass index, blood lipids and hepato-enzymes in 1 163 patients with non-alcoholic fatty liver disease]. | 2010 | Details |
A25934 | 21302121 | J Gastroenterol | Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period. | 2011 | Details |
A25935 | 21301010 | Ann Hepatol | Relation of osteocalcin with insulin resistance and histopathological changes of non alcoholic fatty liver disease. | 2011 | Details |
A25936 | 21301007 | Ann Hepatol | Nonalcoholic fatty liver disease in Brazil. Clinical and histological profile. | 2011 | Details |
A25938 | 21299150 | Acta Gastroenterol Belg | Dietary lipids and NAFLD: suggestions for improved nutrition. | 2011 | Details |
A25939 | 21292470 | J Nutr Biochem | Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms. | 2011 | Details |
A25940 | 21292299 | Hum Pathol | Insulin-like growth factor I receptor β expression in hepatocellular carcinoma. | 2011 | Details |
A25941 | 21288446 | Zhong Xi Yi Jie He Xue Bao | [Treatment of non-alcoholic fatty liver disease based on traditional Chinese medicine therapies for warming yang to activate qi]. | 2011 | Details |
A25942 | 21286345 | Hepatol Int | Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease. | 2010 | Details |
A25943 | 21284669 | Alcohol Clin Exp Res | Genetics of liver injury and fibrosis. | 2011 | Details |
A25945 | 21281435 | Liver Int | Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study. | 2011 | Details |
A25947 | 21280192 | Liver Transpl | Endoplasmic reticulum stress is a mediator of posttransplant injury in severely steatotic liver allografts. | 2011 | Details |
A25948 | 21278140 | Diabetes Care | Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study. | 2011 | Details |
A25950 | 21274868 | Hepatology | Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance. | 2010 | Details |
A25951 | 21274866 | Hepatology | Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease. | 2010 | Details |
A25953 | 21274430 | Gastroenterol Res Pract | Role of toll-like receptors and their downstream molecules in the development of nonalcoholic Fatty liver disease. | 2011 | Details |
A25954 | 21270117 | Gut | Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C. | 2011 | Details |
A25955 | 21269482 | Lipids Health Dis | Comparison of dietary control and atorvastatin on high fat diet induced hepatic steatosis and hyperlipidemia in rats. | 2011 | Details |
A25956 | 21268374 | Recenti Prog Med | [Recent knowledge on the pathogenesis of nonalcoholic fatty liver disease. Role of genetic factors]. | 2010 | Details |
A25957 | 21267748 | J Gastroenterol | Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy. | 2011 | Details |
A25958 | 21266239 | Methods Enzymol | Measurement of ER stress response and inflammation in the mouse model of nonalcoholic fatty liver disease. | 2011 | Details |
A25959 | 21265881 | J Gastroenterol Hepatol | Plasma reactive carbonyl species levels and risk of non-alcoholic fatty liver disease. | 2011 | Details |
A25960 | 21261989 | Nutr Metab (Lond) | Dietary cholesterol, female gender and n-3 fatty acid deficiency are more important factors in the development of non-alcoholic fatty liver disease than the saturation index of the fat. | 2011 | Details |
A25961 | 21261727 | J Gastroenterol Hepatol | Reversal of hepatic steatosis by omega-3 fatty acids measured non-invasively by (1) H-magnetic resonance spectroscopy in a rat model. | 2011 | Details |
A25962 | 21261398 | IET Syst Biol | Investigation of IL-6 and IL-10 signalling via mathematical modelling. | 2011 | Details |
A25963 | 21258197 | Korean J Gastroenterol | Validation of P2/MS and other noninvasive fibrosis scoring systems in the Korean population with nonalcoholic fatty liver disease. | 2011 | Details |
A25964 | 21256907 | J Hepatol | Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease. | 2011 | Details |
A25965 | 21256090 | Epilepsy Behav | Nonalcoholic fatty liver disease in adolescents receiving valproic acid. | 2011 | Details |
A25966 | 21255792 | J Comp Pathol | Role of AMP-activated protein kinase and adiponectin during development of hepatic steatosis in high-fat diet-induced obesity in rats. | 2011 | Details |
A25967 | 21254970 | Curr Med Chem | In vitro models for the study of non-alcoholic fatty liver disease. | 2011 | Details |
A25968 | 21254896 | Ann Med | Association of liver enzymes with metabolic syndrome and carotid atherosclerosis in young adults. The Cardiovascular Risk in Young Finns Study. | 2011 | Details |
A25969 | 21254180 | Hepatology | Noninvasive assessment of liver fibrosis. | 2010 | Details |
A25971 | 21251450 | Acta Dermatovenerol Croat | Metabolic comorbidities and psoriasis. | 2010 | Details |
A25972 | 21251033 | Aliment Pharmacol Ther | Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease. | 2011 | Details |
A25973 | 21250982 | Eur J Clin Invest | Altered distribution of caveolin-1 in early liver steatosis. | 2011 | Details |
A25974 | 21249309 | Biol Res | Cytoprotective and suicidal signaling in oxidative stress. | 2010 | Details |
A25975 | 21248661 | Transplantation | NAFLD recurrence in liver transplant recipients. | 2011 | Details |
A25976 | 21246004 | World J Gastroenterol | Potential efficacy of ginger as a natural supplement for nonalcoholic fatty liver disease. | 2011 | Details |
A25977 | 21245286 | Drug Metab Dispos | Hepatic pharmacokinetics of cationic drugs in a high-fat emulsion-induced rat model of nonalcoholic steatohepatitis. | 2011 | Details |
A25978 | 21245030 | J Lipid Res | Genetic determinants of hepatic steatosis in man. | 2011 | Details |
A25979 | 21244687 | BMC Res Notes | Comparative nucleic acid transfection efficacy in primary hepatocytes for gene silencing and functional studies. | 2011 | Details |
A25980 | 21240660 | Obes Surg | Hepatic expression of adiponectin receptors increases with non-alcoholic fatty liver disease progression in morbid obesity in correlation with glutathione peroxidase 1. | 2011 | Details |
A25981 | 21240032 | Pancreas | Effect of different obesogenic diets on pancreatic histology in Ossabaw miniature swine. | 2011 | Details |
A25982 | 21240014 | J Pediatr Gastroenterol Nutr | Acetaminophen pharmacokinetics in children with nonalcoholic fatty liver disease. | 2011 | Details |
A25983 | 21240012 | J Pediatr Gastroenterol Nutr | Relations of steatosis type, grade, and zonality to histological features in pediatric nonalcoholic fatty liver disease. | 2011 | Details |
A25984 | 21238518 | J Hepatol | C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients. | 2011 | Details |
A25985 | 21237679 | Acad Radiol | The Possibility of differentiation between nonalcoholic steatohepatitis and fatty liver in rabbits on Gd-EOB-DTPA-enhanced open-type MRI scans. | 2011 | Details |
A25988 | 21233280 | Am J Physiol Gastrointest Liver Physiol | Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice. | 2011 | Details |
A25989 | 21233083 | Arch Dis Child | Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial. | 2011 | Details |
A25990 | 21232116 | World J Surg Oncol | An operative case of hepatic pseudolymphoma difficult to differentiate from primary hepatic marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. | 2011 | Details |
A25991 | 21228496 | J Nutr Sci Vitaminol (Tokyo) | Serum cytokeratin 18 M30 antigen level and its correlation with nutritional parameters in middle-aged Japanese males with nonalcoholic fatty liver disease (NAFLD). | 2010 | Details |
A25992 | 21227598 | Pathol Res Pract | Experimental study of non-alcoholic fatty liver disease (NAFLD) on a model of starving chickens: is generalization of steatosis accompanied by fibrosis of the liver tissue? | 2011 | Details |
A25993 | 21226276 | Nihon Rinsho | [Chronic liver disease and arteriosclerosis]. | 2011 | Details |
A25994 | 21199528 | J Gastroenterol Hepatol | Nonalcoholic fatty liver in Asia: Firmly entrenched and rapidly gaining ground. | 2011 | Details |
A25995 | 21199527 | J Gastroenterol Hepatol | Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan. | 2011 | Details |
A25996 | 21225497 | Pol J Pathol | Liver visfatin expression in morbidly obese patients with nonalcoholic fatty liver disease undergoing bariatric surgery. | 2010 | Details |
A25997 | 21225151 | Arq Gastroenterol | Experimental induction of steatosis in different tissues after the ingestion of a carbohydrate-rich diet: effect on the liver, on the heart and on indicators of oxidation. | 2011 | Details |
A25998 | 21224674 | Gan To Kagaku Ryoho | [A case of ruptured hepatocellular carcinoma originated from nonalcoholic steatohepatitis (NASH)]. | 2010 | Details |
A25999 | 21224501 | J Physiol Pharmacol | The pilot study of 3-month course of melatonin treatment of patients with nonalcoholic steatohepatitis: effect on plasma levels of liver enzymes, lipids and melatonin. | 2010 | Details |
A26000 | 21223809 | Zhonghua Yi Xue Za Zhi | [Relationship between liver fat content and liver enzymes in individuals with various statuses of glucose metabolism]. | 2010 | Details |
A26001 | 21222589 | Curr Drug Metab | Does hepatic steatosis affect drug metabolizing enzymes in the liver? | 2011 | Details |
A26003 | 21220846 | Niger J Clin Pract | The contribution of alcohol to chronic liver disease in patients from South-west Nigeria. | 2010 | Details |
A26004 | 21218508 | Diabetes Metab Res Rev | Metformin and atorvastatin combination further protect the liver in type 2 diabetes with hyperlipidaemia. | 2011 | Details |
A26005 | 21216282 | Biochim Biophys Acta | Lipotoxicity and steatohepatitis in an overfed mouse model for non-alcoholic fatty liver disease. | 2011 | Details |
A26006 | 21216209 | Endocrinol Nutr | [Fatty liver and its clinical management in obese adolescents]. | 2011 | Details |
A26007 | 21212755 | Am J Gastroenterol | Effect of atorvastatin, vitamin E and C on nonalcoholic fatty liver disease: is the combination required? | 2011 | Details |
A26009 | 21206486 | Am J Gastroenterol | Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. | 2011 | Details |
A26011 | 21206006 | Dis Markers | Association of hypoadiponectinemia with hypoglutathionemia in NAFLD subjects with and without type 2 diabetes. | 2010 | Details |
A26012 | 21205607 | Orv Hetil | [Role of the brain in the regulation of metabolism and energy expenditure: the central role of insulin, and insulin resistance of the brain]. | 2011 | Details |
A26013 | 21199201 | Hepatol Res | Carnosic acid prevents obesity and hepatic steatosis in ob/ob mice. | 2011 | Details |
A26014 | 21198831 | J Gastroenterol Hepatol | Biomarkers of liver fibrosis. | 2011 | Details |
A26015 | 21198708 | Aliment Pharmacol Ther | Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. | 2010 | Details |
A26016 | 21198182 | J Biomed Opt | Nonlinear microscopy of lipid storage and fibrosis in muscle and liver tissues of mice fed high-fat diets. | 2011 | Details |
A26017 | 21196652 | Saudi J Gastroenterol | Predictors of non-alcoholic fatty liver disease in obese and overweight Egyptian children: single center study. | 2011 | Details |
A26018 | 21192835 | Proteome Sci | Clinical proteomics for liver disease: a promising approach for discovery of novel biomarkers. | 2010 | Details |
A26019 | 24688911 | Health Promot Perspect | Lifestyle Modification through Dietary Intervention: Health Promotion of Patients with Non-Alcoholic Fatty Liver Disease. | 2011 | Details |
A26020 | 22629789 | Eksp Klin Gastroenterol | [UDCA in the treatment of nonalcoholic fatty liver disease]. | 2011 | Details |
A26021 | 22629725 | Eksp Klin Gastroenterol | [UDCA in the treatment of nonalcoholic fatty liver disease]. | 2011 | Details |
A26022 | 22629718 | Eksp Klin Gastroenterol | [Metabolic syndrome and nonalcoholic fatty liver diseases in children]. | 2011 | Details |
A26023 | 22580727 | Rev Diabet Stud | Hepatic steatosis in type 1 diabetes. | 2012 | Details |
A26024 | 22568272 | Rom J Intern Med | Depression and anxiety in nonalcoholic steatohepatitis: is there any association? | 2011 | Details |
A26025 | 22566839 | Front Immunol | New insights into the role of macrophages in adipose tissue inflammation and Fatty liver disease: modulation by endogenous omega-3 Fatty Acid-derived lipid mediators. | 2011 | Details |
A26026 | 21191681 | Indian J Gastroenterol | Nonalcoholic fatty liver disease in India - a lot done, yet more required! | 2010 | Details |
A26027 | 21190824 | J Nutr Biochem | A mouse model for nonalcoholic steatohepatitis. | 2010 | Details |
A26028 | 21190397 | Ups J Med Sci | A preliminary investigation on the possible association between diminished copper availability and non-alcoholic fatty liver disease in epileptic patients treated with valproic acid. | 2010 | Details |
A26029 | 21188334 | J Gastrointestin Liver Dis | An overview of nonalcoholic steatohepatitis: past, present and future directions. | 2010 | Details |
A26030 | 21187187 | Am J Med | Hyperinsulinemia and the development of nonalcoholic Fatty liver disease in nondiabetic adults. | 2011 | Details |
A26031 | 21184788 | J Hepatol | Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats. | 2010 | Details |
A26032 | 21184786 | J Hepatol | Deletion of steroid receptor coactivator-3 gene ameliorates hepatic steatosis. | 2010 | Details |
A26033 | 21184785 | J Hepatol | Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis. | 2010 | Details |
A26034 | 21182485 | Curr Med Chem | Toward a biochemical diagnosis of NASH: insights from pathophysiology for distinguishing simple steatosis from steatohepatitis. | 2011 | Details |
A26035 | 21182227 | World J Gastroenterol | High prevalence of nonalcoholic fatty liver in patients with idiopathic venous thromboembolism. | 2010 | Details |
A26036 | 21182129 | J Magn Reson Imaging | Liver methylene fraction by dual- and triple-echo gradient-echo imaging at 3.0T: Correlation with proton MR spectroscopy and estimation of robustness after SPIO administration. | 2011 | Details |
A26038 | 21180596 | Therap Adv Gastroenterol | Treatment options for nonalcoholic fatty liver disease. | 2010 | Details |
A26039 | 21179000 | Int J Obes (Lond) | Reproducibility of glucose, fatty acid and VLDL kinetics and multi-organ insulin sensitivity in obese subjects with non-alcoholic fatty liver disease. | 2010 | Details |
A26040 | 21178608 | Curr Opin Clin Nutr Metab Care | Nonalcoholic fatty liver disease in children. | 2011 | Details |
A26041 | 21176169 | BMC Med Genet | Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease. | 2010 | Details |
A26042 | 21173431 | Carcinogenesis | Constitutive active/androstane receptor promotes hepatocarcinogenesis in a mouse model of non-alcoholic steatohepatitis. | 2010 | Details |
A26043 | 21172393 | J Hepatol | Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease. | 2010 | Details |